Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF JANUARY 20,1995 PSA#1266

U.S. ARMY MED. RESEARCH ACQUISITION ACT, MCMR-RMA-RC, FORT DETRICK BLDG. 820, FREDERICK MD 21702-5014

A -- SOURCES SOUGHT SOL DAMD17-CBD5-0007 DUE 033195 POC Patricia M. McAllister, Contracting Officer, (301) 619-7360 The U.S. Army Medical Research and Materiel Command is currently seeking basic research proposals to develop an immunoassay for quantitating thiodiglycol (2,2'-thiodiethanol) in urine and other biological fluids. The immunoassay should demonstrate the specificity and sensitivity necessary to be used as a screen for thiodiglycol in urine samples and biological fluids. Also the immunoassay method should be simple and portable for use in the field. The offerer is expected to have expertise in monoclonal antibody technology. In addition, the offerer's facility should be currently fully operational for such work. While the offerer chosen for award of any contract is not limited to use Government supplied haptens to aid in the development of a monoclonal antibody for thiodiglycol, the offerer may obtain from the Government four haptens to use in preparing test antigens and immunizing antigens. Available Government supplied haptens are: (a) Set 1. 4-(2-hydroxyethyl) benzoic acid for the preparation of an immunizing antigen and 8-hydroxyoctanoic acid for the preparation of the test antigen, and (b) Set 2. 4-(2-hydroxyethylthio) benzoic acid for the preparation of an immunizing antigen and 6-(2-hydroxyethylthio) hexanoic acid for the preparation of the test antigen. Following both contractor and Army characterization of the monoclonal antibodies produced by the offerer, the offerer will produce 500 milligrams of the monoclonal antibody selected by the Army. All cell lines developed during the investigation will become the property of the Army following completion of the project. Proposers are encouraged to survey the open literature on this topic prior to submitting their research ideas in a preproposal for Army review. This research will support a program on medical countermeasures against vesicating chemical warfare agents. This acquisition is reserved for exclusive participation by Historically Black College/Universities (HBCU), Minority Institutions (MI) and Small and Disadvantaged Businesses (SDB). Proposals may be submitted during the period 1 October 1994 through 31 March 1995. Proposals received under the set-aside will be reviewed and evaluated separately from other research proposals. If no acceptable proposals are received under these set- asides during these time periods, these areas will then become unrestricted and proposals may be submitted by any interested party. Write to the Contracting Officer in number 7. above for instructions regarding submission of preproposals under the Broad Agency Announcement. (0018)

Loren Data Corp. http://www.ld.com (SYN# 0018 19950119\A-0018.SOL)


A - Research and Development Index Page